News

News

Press Release

Machine Learning Visionary, David Heckerman, Joins Human Longevity, Inc. as Chief Data Scientist

SAN DIEGO, CA, March 21, 2017 – Human Longevity, Inc., the genomics–powered, health intelligence company, announced today that David Heckerman, M.D., PhD., a 25-year veteran of Microsoft, has joined the company as the Chief Data Scientist. Dr. Heckerman, who will report to J. Craig Venter, Ph.D., HLI Co-founder, Executive Chairman and head of scientific strategy, will lead an advanced analytics team at HLI’s Mountain View, CA, office to continue to tackle some of the most important challenges in the analysis of large-scale medical and genomic data.

Continue Reading
Partner Releases

The Worth Group Unveils First Health and Wellness Summit

Selects San Diego as Host Location, Announces Partnership with Human Longevity Inc. (HLI)

Continue Reading
Press Releases

Machine Learning Visionary, David Heckerman, Joins Human Longevity, Inc. as Chief Data Scientist

SAN DIEGO, CA, March 21, 2017 – Human Longevity, Inc., the genomics–powered, health intelligence company, announced today that David Heckerman, M.D., PhD., a 25-year veteran of Microsoft, has joined the company as the Chief Data Scientist. Dr. Heckerman, who will report to J. Craig Venter, Ph.D., HLI Co-founder, Executive Chairman and head of scientific strategy, […]

Continue Reading
Press Releases

Human Longevity, Inc. and MassMutual Sign Groundbreaking Agreement to Offer HLIQ™ Whole Genome Sequencing to MassMutual’s Customers, Financial Professionals and Employees

SAN DIEGO, Calif. and SPRINGFIELD, Mass. – March 15, 2017— Human Longevity, Inc. (HLI), the genomics-based, health intelligence company and Massachusetts Mutual Life Insurance Co. (MassMutual), announced today they have signed an innovative multi-year agreement to offer HLI’s whole genome sequencing product, HLIQ Whole Genome, to eligible MassMutual customers, employees and financial professionals at a […]

Continue Reading
Press Releases

In Largest Whole Genome Sequence Analysis Study, Human Longevity, Inc.-Led Team Identifies Common-to-Rare Variants in the Human Blood Metabolome

The study shows the power of whole genome sequencing and analysis to uncover new variants missed in exome or genotyping arrays (SAN DIEGO, CA)—March 6, 2017—Researchers from Human Longevity, Inc. (HLI), the genomics-based, health intelligence company, have published results from the largest whole genome sequencing and analysis of blood metabolites. They were able to link […]

Continue Reading
Press Releases

Human Longevity, Inc. Hires Cynthia Collins, Healthcare Industry Leader, as New Chief Executive Officer

Craig Venter, Ph.D., Co-founder and former CEO, will remain at Company as Executive Chairman and continue in full time role guiding scientific vision and strategy (SAN DIEGO, CA)—January 4, 2017—Human Longevity, Inc. (HLI), the genomics-driven, health intelligence company, today announced Cynthia Collins as the new Chief Executive Officer effective January 9, 2017. Collins, who has […]

Continue Reading
News Alerts

Embracing the Perks of Cloud Computing

By Yaron Turpaz, Ph.D., MBA, CIO, Human Longevity, Inc. Human Longevity, Inc. was launched in March 2014 with a mission to transform healthcare and accelerate the practice of personalized, preventive healthcare via detailed and comprehensive genomics analysis and risks assessment, in integration with high quality phenotypic and medical information. We have built the largest human […]

Continue Reading
News Alerts

National Academy of Medicine Elects 79 New Members

J. Craig Venter, Ph.D. among inductees

Continue Reading
Press Releases

Researchers from Human Longevity, Inc. Publish Paper Detailing Results of Deep Sequencing of 10,545 Human Genomes

Paper outlines 150 million rare or unknown variants; approximately 8,500 novel variants per genome Company also unveils new genome search engine, HLI Open Search, for beta testing

Continue Reading
Press Releases

Human Longevity, Inc. Announces 10 Year Deal with AstraZeneca to Sequence and Analyze Patient Samples from AstraZeneca Clinical Trials

(SAN DIEGO, CA)—April 21, 2016—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company working to revolutionize the practice of medicine, announced today a 10 year deal with AstraZeneca to sequence and analyze up to 500,000 DNA samples from AstraZeneca clinical trials. The genomic insights from the collaboration will be added to the HLI Knowledgebase™, building upon […]

Continue Reading
Partner Releases

StartUp Health Launches ‘Longevity Moonshot’ and Invests in Human Longevity, Inc. to Change Face of Aging

New York, NY (PRWEB)April 13, 2016 — StartUp Health, a global organization leading the movement to transform health by building the world’s largest community of Healthcare Transformers, today announced the launch of StartUp Health’s Longevity Moonshot, a mission to extend and enhance healthy life by 50+ years and change the face of aging. Marked by […]

Continue Reading

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets